Summary
With a new formulation, which made intravenous infusion of triamterene (TA) possible, plasma levels and urinary excretion rates of TA and its main metabolite (OH-TA-ester) were measured in a randomized, cross-over trial in 6 healthy volunteers given triamterene 10 mg i.v. and 50 mg p.o. TA and OH-TA-ester were determined by densitometric measurement of native fluorescence after thin layer chromatography. Distribution volumes of the central compartment of TA and OH-TA-ester were 1.49 l/kg and 0.11 l/kg, respectively. Terminal half-lives were 255 min for TA and 188 min for OH-TA-ester after i.v. administration. For TA total plasma clearance was 4.5 l/min and renal plasma clearance 0.22 l/kg. The formation of OH-TA-ester was very rapid and the concentration of the metabolite exceeded that of TA at all times. After i.v. administration the urinary recovery of TA and OH-TA-ester was 4.4% and 50.9%, respectively. The bioavailability of TA was 52%, corresponding to absorption of 83%. TA is partly eliminated by a first-pass-effect. The main metabolite of TA is OH-TA-ester, which is pharmacologically active.
Similar content being viewed by others
References
Andrasch H, Fink T, Schmid E (1971) Über die Harnausscheidung des Antikaliuretikums Triamteren und seines phenolischen Metaboliten 2,4,7-Triamino-6-p-hydroxyphenylpteridin bei Lebergesunden und Kranken mit Leberzirrhose. Z. Gastroenterol 9: 240–245
Benet LZ, Galeazzi RL (1979) Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 68: 1071–1074
D'Argenio DZ, Schumitzky A (1979) A program package for simulation and parameter estimation in pharmacokinetic systems. Comput Programs Biomed 9: 115–134
Grebian B, Geißler HE, Knauf H, Mutschler E, Schnippenkoetter I, Völger K-D, Wais U (1978) Zur Pharmakokinetik von Triamteren und seinen wirksamen Metaboliten bei eingeschränkter Nierenfunktion. Arzneim-Forsch 28: 1420–1425
Grebian B, Geißler HE, Mutschler E (1976) Über die Bestimmung von Triamteren, Hydroxytriamteren und Hydroxytriamteren-schwefelsäureester in biologischem Material durch direkte Auswertung von Dünnschichtchromatogrammen. Arzneim-Forsch 26: 2125–2127
Gundert-Remy U, von Kenne D, Weber E, Geißler HE, Grebian B, Mutschler E (1979) Plasma and urinary levels of triamterene and certain metabolites after oral administration to man. Eur J Clin Pharmacol 16: 39–44
Knauf H, Möhrke W, Mutschler E, Völger K-D (1980) Zur Bioverfügbarkeit von Hydrochlorothiazid und Triamteren aus Fertigarzneimitteln. Arzneim-Forsch 30: 1001–1004
Knauf H, Mutschler E, Völger K-D, Wais U (1978) Pharmakologische Wirksamkeit von Phase-I- und Phase-II-Metaboliten des Triamteren. Arzneim-Forsch 28: 1417–1420
Kramer J, Rörig M, Völger K-D (1981) Effects of triamterene and its phase I and phase II metabolites on sodium transport of the isolated frog skin. Pharmacology 23: 149–155
Lehmann K (1965) Trennung, Isolierung und Identifizierung von Stoffwechselprodukten des Triamterens. Arzneim-Forsch 15: 812–816
Leilich G, Knauf H, Mutschler E, Völger K-D (1980) Influence of triamterene and hydroxytriamterene sulfuric acid ester on diuresis and saluresis in rats after oral and intravenous application. Arzneim-Forsch 30: 949–953
Marvola M, Taskinen R, Eriksson M, Hietula M (1981) Bioavailability of hydrochlorothiazide and triamterene in some individual and combination preparations. Acta Pharm Fenn 90: 265–273
Mudge GH (1975) Diuretics and other agents employed in the mobilization of edema fluid. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 817–847
Pruitt AW, Winkel JS, Dayton PG (1977) Variations in the fate of triamterene. Clin Pharmacol Ther 21: 610–619
Stüber W, Mutschler E, Steinbach D (1980) Untersuchungen zur Korrelierbarkeit von In-vitro- und In-vivo-Daten am Beispiel von Triamteren-Fertigarzneimitteln. Arzneim-Forsch 30: 1158–1163
Sved S, Sertié JAA (1979) The assay of triamterene in human blood by ion-pair extraction and high performance liquid chromatography. National Bureau of Standards Special Publication 519, Trace Organic Analysis, pp 477–480
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilfrich, H.J., Kremer, G., Möhrke, W. et al. Pharmacokinetics of triamterene after i.v. administration to man: Determination of bioavailability. Eur J Clin Pharmacol 25, 237–241 (1983). https://doi.org/10.1007/BF00543797
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00543797